Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 1998, p. 959-962, Vol. 42, No. 4
Department of Medicine and Department of
Molecular Biology and Microbiology,
Received 23 October 1997/Returned for modification 3 December
1997/Accepted 20 January 1998
The aarE1 allele was identified on the basis of the
resulting phenotype of increased aminoglycoside resistance. The
aarE1 mutation also resulted in a small-colony phenotype
and decreased levels of aac(2')-Ia mRNA. The deduced AarE
gene product displayed 61% amino acid identity to the
Escherichia coli UbiA protein, an octaprenyltransferase
required for the second step of ubiquinone biosynthesis.
Complementation experiments in both Providencia stuartii
and E. coli demonstrated that aarE and
ubiA are functionally equivalent.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutations in aarE, the ubiA
Homolog of Providencia stuartii, Result in High-Level
Aminoglycoside Resistance and Reduced Expression of the Chromosomal
Aminoglycoside 2'-N-Acetyltransferase
*
Corresponding author. Mailing address: Infectious
Diseases Section 1110W, Wade Park Medical Center, 10701 E. Boulevard,
Cleveland, OH 44106. Phone: (216) 368-0744. Fax: (216) 368-2034. E-mail: pxr17{at}po.cwru.edu.
Antimicrobial Agents and Chemotherapy, April 1998, p. 959-962, Vol. 42, No. 4
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»